Invention Application
- Patent Title: PYRROLOPYRIMINDINE CDK9 KINASE INHIBITORS
- Patent Title (中): 吡咯烷酮CDK9激酶抑制剂
-
Application No.: US14207868Application Date: 2014-03-13
-
Publication No.: US20140275004A1Publication Date: 2014-09-18
- Inventor: Alan S. Florjancic , Yunsong Tong , Thomas D. Penning , Andrew J. Souers , Rajeev Goswami
- Applicant: AbbVie Inc.
- Priority: IN744/DEL/2013 20130314
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/519
Abstract:
Disclosed are compound of Formula (Ia), wherein R1, R2, and R3 are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds may be used as agents in the treatment of diseases, including cancer. Also provided are pharmaceutical compositions, comprising one or more compounds of Formula (Ia).
Public/Granted literature
- US09346813B2 Substituted pyrrolo[2,3-d]pyrimindines as CDK9 kinase inhibitors Public/Granted day:2016-05-24
Information query
